Study of Remote Care Using a 4G Tablet for Patients with Low-Risk Thromboembolic Disease

What this Trial Is About

Researchers are evaluating the feasibility and impact of remote care for patients diagnosed with low-risk thromboembolic disease. The study aims to understand how well healthcare professionals, including hospital physicians and primary care doctors, can organize care remotely, and to assess rates of complications, hospitalizations, and treatment compliance over 6 months and 1 year. Participants will follow treatment guidelines based on national recommendations. Participants will receive a 4G tablet for the entire study period to complete questionnaires, access educational information about their medications, participate in remote consultations, and track their treatment adherence. The study focuses on measuring satisfaction with the organization of care by patients and healthcare providers, along with monitoring clinical outcomes related to thromboembolic disease. During the study, participants will be regularly assessed through questionnaires and remote consultations using the tablet. Researchers will evaluate satisfaction levels using three different scales for patients, hospital physicians, and primary care physicians at 6 months and 1 year. They will also monitor complication rates, hospitalizations related to thromboembolic disease, and treatment compliance at these time points. The total duration of participation spans at least one year with ongoing monitoring and data collection.

Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk